(Q42631482)

4 November 2017

title

The WASH study (Warfarin/Aspirin Study in Heart failure) rationale, design and end-points (English)

1 reference

4 November 2017

1 reference

1 reference

WASH

1

1 reference

4 November 2017

publication date

1 March 1999

1 reference

European Journal of Heart Failure

4 November 2017

March 1999

0 references

published in

1 reference

4 November 2017

volume

1

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

95-99

1 reference

Recognising the limits of randomized clinical trials.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Anticoagulant and antiplatelet therapy in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Mode of death in chronic heart failure. A request and proposition for more accurate classification

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Frequency of magnetic resonance signal abnormalities of the brain in patients aged less than 50 years with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Is aspirin safe for patients with heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Endothelium-dependent modulation of responses to endothelin-I in human veins

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

COX provides missing link in mechanism of aspirin in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900007-5

7 January 2021

10.1016/S1388-9842(98)00007-5

Identifiers

DOI

0 references

1 reference